Capital Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Capital Bank & Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-484,694	Closed	-$50.2M	–	73
2021 Q2	$50.2M	Buy	484,694 +179,513	+59%	+$16.9M	0.58%	61
2021 Q1	$25.5M	Sell	305,181 -3,345	-1%	-$283K	0.3%	87
2020 Q4	$28.1M	Sell	308,526 -920	-0.3%	-$76.3K	0.34%	82
2020 Q3	$24.7M	Buy	309,446 +2,352	+0.8%	+$184K	0.33%	82
2020 Q2	$21.2M	Buy	307,094 +7,544	+3%	+$536K	0.31%	76
2020 Q1	$18.8M	Sell	299,550 -13,728	-4%	-$990K	0.32%	79
2019 Q4	$24.4M	Buy	313,278 +42,921	+16%	+$3.35M	0.32%	81
2019 Q3	$19.8M	Buy	270,357 +74,661	+38%	+$5.24M	0.27%	85
2019 Q2	$12.1M	Buy	195,696 +195,498	+98,736%	+$11.8M	0.15%	110
2019 Q1	$13K	Sell	198 -975	-83%	-$55.6K	﹤0.01%	506
2018 Q4	$60K	Buy	1,173 +975	+492%	+$49.3K	﹤0.01%	398
2018 Q3	$11K	Hold	198	–	–	﹤0.01%	651
2018 Q2	$10K	Hold	198	–	–	﹤0.01%	533
2018 Q1	$9K	Hold	198	–	–	﹤0.01%	528
2017 Q4	$7K	Buy	+198	New	+$7.27K	﹤0.01%	578
2017 Q3	–	Sell	-165	Closed	-$7K	–	603
2017 Q2	$7K	Buy	+165	New	+$6.02K	﹤0.01%	487

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Bank & Trust's EW Position: Q3 2021 in Review

Capital Bank & Trust sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 484,694 shares — an estimated $50.2M sold.

Capital Bank & Trust first reported a position in EW in Q2 2017 and held it in 16 quarters. The position peaked at $50.2M in Q2 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Capital Bank & Trust reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
Capital Bank & Trust sold 484,694 Edwards Lifesciences shares in Q3 2021, an estimated $50.2M.
Capital Bank & Trust first reported a position in Edwards Lifesciences in Q2 2017 and held it in 16 quarters.
Capital Bank & Trust's Edwards Lifesciences position peaked at $50.2M in Q2 2021.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.